Prestige Consumer Healthcare (PBH) Acquisitions (2010 - 2022)
Prestige Consumer Healthcare's (PBH) quarterly Acquisitions came in at $132000.0 in Q1 2022, down 99.27% quarter-over-quarter from $18.0 million in Q4 2021.
Prestige Consumer Healthcare (PBH) Acquisitions (2010 - 2022) Analysis & Trends
Prestige Consumer Healthcare's Acquisitions history runs 8 years deep, the most recent figure standing at $132000.0 for Q1 2022.
- On a quarterly basis, Acquisitions changed N/A year-over-year to $132000.0 in Q1 2022; TTM through Mar 2023 was $18.1 million, a 0.0% change from a year earlier, with the FY2022 full-year figure at $247.0 million, changed N/A from the prior year.
- Acquisitions fell to $132000.0 in Q1 2022 per PBH's latest filing, from $18.0 million in the prior quarter.
- Across five years, Acquisitions topped out at $18.0 million in Q4 2021 and bottomed at $132000.0 in Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Prestige Consumer Healthcare | 2.34 Bn | 2.28 Bn | 157.37 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 132,000.00 |
| Dec 31, 2021 | 18.00 Mn |
| Jun 30, 2017 | 970,000.00 |
| Mar 31, 2017 | -1.40 Mn |
| Dec 31, 2016 | 1.40 Mn |
| Mar 31, 2016 | 226.98 Mn |
| Dec 31, 2014 | -77.99 Mn |
| Jun 30, 2014 | 77.99 Mn |
| Mar 31, 2012 | 661.60 Mn |
| Mar 31, 2011 | -202.04 Mn |
| Dec 31, 2010 | 202.04 Mn |